University of Florida neuroscientists have made a mechanistic discovery that paves the way to test immune-modulating ...
Illumina launched the Billion Cell Atlas to train AI on one billion single cells. AstraZeneca, Merck and Lilly are founding ...
For decades, scientists have investigated the neurokinin-1 receptor (NK1R) as a potential target for treating major ...
Morning Overview on MSN
Scientists watch drug molecules hit cell receptors in real time
Drug discovery is shifting from static snapshots to moving pictures. Instead of inferring how medicines work from end results ...
News-Medical.Net on MSN
OutSee completes seed funding round and establishes partnership with o2h discovery for lead drug target candidate
OutSee, a genomics and drug discovery company pioneering a unique AI-based predictive genomics approach to target discovery, today announced the closure of its £2.5 M seed funding round.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback